Biotech startup with AlphaGo-type AI approach snags $30M

Biotech startup with AlphaGo-type AI approach snags $30M

Source: 
MedCity News
snippet: 

The CEO of Anagenex believes that the company's AI engine trained on billions of data points and iterative testing will blow other AI drug discovery startups out of the water.